Customceutical Compounding Recalls Test PROCYP Injectable Due to Sterility Concerns
Customceutical Compounding is recalling Test PROCYP injectable vials because the company cannot guarantee the product is sterile.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source text identifies a lack of sterility assurance for an injectable product, which poses a significant risk of serious injury or infection. Per the rubric, significant injury reports or structural defects in high-risk products align with a Severe rating.
Plain-English summary
Customceutical Compounding is voluntarily recalling Test PROCYP (Testosterone Cypionate 200mg/ml and Testosterone Propionate 20mg/ml) 5 ml multidosed vials. The recall was initiated because the firm lacks assurance of sterility for these injectable solutions. The affected product is identified by Lot # 03112019@10 and has an expiration date of 6/19/19.
The recall covers products distributed nationwide in the United States. The FDA has classified this recall as Class II, indicating that use of the product could cause temporary or medically reversible health consequences.
Consumers who have this product should stop using it and contact Customceutical Compounding at 480 516 0272 for instructions on how to return the product or obtain a refund.
The recalled product
- Product
- Test PROCYP (TESTOSTERONE CYPIONATE 200MG/ML TESTOSTERONE PROPIONATE 20MG/ML), 5 ML MULTIDOSE VIAL INJ COMPOUNDED. Customceutical Compounding 4611 E. Shea Blvd. Bldg 3 180, Phoenix, AZ 85028 Ph. 480 516 0272
- Manufacturer
- Customceutical Compounding
- Affected units
- 5
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 03112019@10
- Exp 6/19/19
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Customceutical Compounding under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Customceutical Compounding
See all →- SevereCustomceutical Compounding Recalls Glutathione Injection Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Lipoplex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls BPlex Injectable Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
- SevereCustomceutical Compounding Recalls Test D Vials Due to Sterility Concerns
FDA (Drugs) · 2019-05-08
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29